Making Symptoms Visible: The Impact of Real-Time PROM Integration in Pediatric Oncology

Natalie Bradford1,2,3, Ethan Whalan1, Paula Condon4

  • 1School of Nursing, Queensland University of Technology, Brisbane, QLD 4101, Australia.

PubMed

Insights

Integrating the Symptom Screening in Pediatrics Tool (SSPedi) improved pediatric cancer symptom detection. Routine use of patient-reported outcome measures (PROMs) can enhance timely interventions for children undergoing cancer treatment.

Area of Science:

  • Pediatric Oncology
  • Clinical Informatics
  • Patient-Reported Outcomes

Background:

  • Children with cancer face numerous undetected symptoms during treatment.
  • Routine care often misses distressing symptoms in pediatric cancer patients.
  • Symptom management is crucial for improving quality of life during cancer therapy.

Purpose of the Study:

  • To assess the impact of integrating the Symptom Screening in Pediatrics Tool (SSPedi) into clinical workflows.
  • To evaluate SSPedi's effectiveness in detecting symptoms in pediatric cancer patients.
  • To understand the implications of improved symptom detection for healthcare service delivery.

Main Methods:

  • Seventy children (aged 4-18) undergoing cancer treatment completed SSPedi weekly for eight weeks.
  • Medical records were audited for symptom documentation and prevalence.
  • SSPedi data was categorized using a clinical algorithm and compared to score-only thresholds.

Main Results:

  • Appetite changes, fatigue, nausea/vomiting, and pain were the most reported symptoms.
  • Severe symptoms were more frequently detected by SSPedi when patients were hospitalized versus at home.
  • Clinical algorithm-based alerts identified more immediate concerns than score-only thresholds, potentially increasing necessary interventions.

Conclusions:

  • Routine integration of patient-reported outcome measures (PROMs) can enhance symptom detection and facilitate timely interventions.
  • Clinical algorithms improve sensitivity for symptom detection but may increase alert burden.
  • Optimizing alert thresholds and redesigning clinical workflows are necessary for effective PROM implementation.

Related Concept Videos

Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
288
Methods of Documentation II: POMR01:26

Methods of Documentation II: POMR

The Problem-Oriented Medical Record (POMR) revolutionized medical record-keeping by introducing a systematic approach focusing on the patient's problems rather than merely listing symptoms. Dr. Lawrence Weed's introduction of this method in the 1960s marked a significant advancement in medical documentation. The POMR framework consists of four key components: the database, problem list, plan of care, and progress notes.
1.5K
Modeling in Therapy01:26

Modeling in Therapy

Modeling, a key technique in therapy, uses observational learning to help clients acquire and practice new skills by watching therapists demonstrate desired behaviors. This approach, rooted in Albert Bandura's concept of vicarious learning, plays a significant role in therapeutic interventions for various psychological conditions, including social anxiety, ADHD, and depression.
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
606
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
384
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
289
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
381